Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction (Q56945403)
article
Language:
(P31) (Q13442814)
(P50) (Q5387640)
(Q19281782)
(P304) 1045-1051
(P407) (Q1860)
(P433) 12
(P478) 77
(P577) Wednesday, May 1, 1996
(P921) (Q79460)
(Q12152)
(Q539795)
(Q18558122)
(Q422248)
(P1433) (Q2208417)
(P1476) "Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators" (language: en)
(P2093) J Lefkovits
R J Ivanhoe
B A Bergelson
K M Anderson
G L Stoner
H F Weisman
(P2860) (Q34117545)
(Q44005205)
(Q41392558)
(Q30466780)
(Q37694282)
(Q34336722)
(Q56945638)
(Q43765794)
(Q33447121)
(Q52534547)
(Q42082355)
(Q42073732)
(Q34360479)
(Q70562091)
(Q43966166)
(Q33383834)
(Q41783750)
(Q69912387)
(Q70063699)
(Q69367792)
(Q70143434)
(Q68352752)
(Q67672764)
(Q67987024)
(Q72791723)
(Q42080571)
(Q72047795)
(Q35597681)
(Q58481514)
other details
description article

External Links